Clarity Pharmaceuticals (ASX:CU6) completes recruitment for its CLARIFY prostate imaging trial, with data due next year.
Clarity Pharmaceuticals completes recruitment for its CLARIFY prostate imaging trial - Kalkine Media
Clarity Pharmaceuticals (ASX:CU6) completes recruitment for its CLARIFY prostate imaging trial, with data due next year.